Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2206447 | 0.96 | — | — | |
| Bromide SCHEMBL4651773 | 0.93 | — | — | |
| Water SCHEMBL357692 | 0.93 | — | — | |
| Iodide SCHEMBL7216934 | 0.93 | — | — | |
| Methylene Chloride SCHEMBL4462021 | 0.91 | — | — | |
| Hydrochloric Acid SCHEMBL10830067 | 0.87 | — | — | |
| SCHEMBL23716908 | 0.83 | — | — | |
| SCHEMBL5744333 | 0.78 | — | — | |
| SCHEMBL10515763 | 0.72 | — | — | |
| SCHEMBL11101962 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1560 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250388600-A1 | A PROCESS FOR THE PREPARATION OF EDOXABAN AND ITS INTERMEDIATES | AMI LIFESCIENCES PRIVATE LIMITED (IN) | 2025-12-25 | — | — | US | claimed |
| EP-4667479-A1 | POLYPHOSPHORYLATED NUCLEOSIDE, PHOSPHATE-ACTIVATED NUCLEOTIDE USED FOR SYNTHESIS OF POLYPHOSPHORYLATED NUCLEOSIDE AND METHOD FOR SYNTHESIS OF SAME, AND METHOD FOR SYNTHESIS OF POLYPHOSPHORYLATED NUCLEOSIDE USING PHOSPHATE-ACTIVATED NUCLEOTIDE | Natias Inc. (JP) | 2025-12-24 | — | — | EP | claimed |
| US-12421270-B2 | Oligosaccharide, preparation method therefor, composition thereof and use thereof | Yantai Dongcheng Biochemicals Co., Ltd (CN) | 2025-09-23 | — | — | US | claimed |
| US-20250228961-A1 | PRACTICAL GLYCAN ENGINEERING METHOD FOR THE PREPARATION OF HOMOGENOUS ANTIBODY CONJUGATES | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2025-07-17 | — | — | US | claimed |
| US-20250162992-A1 | METHOD FOR PRODUCING AMIDE COMPOUND | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-05-22 | — | — | US | claimed |
| CN-119978873-A | Preservative composition and application thereof in anti-corrosion high-temperature-resistant coating | 陈向坤 | 2025-05-13 | — | — | CN | claimed |
| US-20250129050-A1 | SYNTHESIS OF A KIF18A INHIBITOR | AMGEN INC. (US) | 2025-04-24 | — | — | US | claimed |
| WO-2025067393-A1 | DISACCHARIDE-ACYLHYDRAZONE OR DISACCHARIDE-HYDRAZIDE LINKER, GLYCO-ENGINEERED ANTIBODY AND SUGAR-CHAIN SITE-DIRECTED ANTIBODY-DRUG CONJUGATE BASED ON SAME, AND USE THEREOF | 上海糖岭生物医药有限责任公司 | 2025-04-03 | — | — | WO | claimed |
| CN-119708088-A | Disaccharide-acylhydrazone or disaccharide-hydrazide linker, sugar engineering antibody based on same, sugar chain fixed-point antibody-drug conjugate and application | 上海糖岭生物医药有限责任公司 | 2025-03-28 | — | — | CN | claimed |
| CN-119708250-A | Solid material with surface glycopeptide molecule chemically modified, modification method and application | 驻马店市中心医院 | 2025-03-28 | — | — | CN | claimed |
| WO-2015134096-A1 | PHARMACEUTICALLY RELEVANT AROMATIC-CATIONIC PEPTIDES | STEALTH PEPTIDES INTERNATIONAL, INC. (MC) | 2015-09-11 | — | — | WO | claimed |
| WO-2015100376-A1 | PHARMACEUTICALLY RELEVANT AROMATIC-CATIONIC PEPTIDES | STEALTH PEPTIDES INTERNATIONAL, INC. (MC) | 2015-07-02 | — | — | WO | claimed |
| WO-2014083367-A1 | PROCESS FOR THE PREPARATION OF TRAVOPROST | CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. (HU) | 2014-06-05 | — | — | WO | claimed |
| US-20140135503-A1 | NOVEL PROCESSES FOR THE PREPARATION OF PROSTAGLANDIN AMIDES | CHINOIN Zrt. (HU) | 2014-05-15 | — | — | US | claimed |
| EP-2723714-A1 | NOVEL PROCESSES FOR THE PREPARATION OF PROSTAGLANDIN AMIDES | Chinoin Zrt. (HU) | 2014-04-30 | — | — | EP | claimed |
| WO-2012164324-A9 | NOVEL PROCESSES FOR THE PREPARATION OF PROSTAGLANDIN AMIDES | CHINOIN Zrt. (HU) | 2014-01-09 | — | — | WO | claimed |
| WO-2012164324-A1 | NOVEL PROCESSES FOR THE PREPARATION OF PROSTAGLANDIN AMIDES | CHINOIN Zrt. (HU) | 2012-12-06 | — | — | WO | claimed |
| US-20070073064-A1 | Method for producing aminopyrrolidine derivatives and intermediate compounds | TEIJIN PHARMA LIMITED (JP) | 2007-03-29 | — | — | US | claimed |
| EP-1676837-A1 | PROCESS FOR PRODUCING AMINOPYRROLIDINE DERIVATIVE AND INTERMEDIATE COMPOUND | Teijin Pharma Limited (JP) | 2006-07-05 | — | — | EP | claimed |
| US-5750779-A | Preparation process of acyl halide or sulfonyl halide | MITSUI TOATSU CHEMICALS, INC. (JP) | 1998-05-12 | — | — | US | claimed |